MX9603556A - Medical application of bromelain. - Google Patents

Medical application of bromelain.

Info

Publication number
MX9603556A
MX9603556A MX9603556A MX9603556A MX9603556A MX 9603556 A MX9603556 A MX 9603556A MX 9603556 A MX9603556 A MX 9603556A MX 9603556 A MX9603556 A MX 9603556A MX 9603556 A MX9603556 A MX 9603556A
Authority
MX
Mexico
Prior art keywords
bromelain
medical application
hypercholesterolaemia
act
treatment
Prior art date
Application number
MX9603556A
Other languages
Spanish (es)
Other versions
MXPA96003556A (en
Inventor
Stephen George Barnwell
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Priority claimed from PCT/GB1995/000352 external-priority patent/WO1995022348A1/en
Publication of MXPA96003556A publication Critical patent/MXPA96003556A/en
Publication of MX9603556A publication Critical patent/MX9603556A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The application relates to the use of bromelain in the treatment of hypercholesterolaemia and similar diseases. Bromelain is able to act as a bile acid receptor antagonist and therefore to prevent reabsorption of bile acids by the gastrointestinal tract.
MX9603556A 1995-02-21 1995-02-21 Medical application of bromelain. MX9603556A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9403344.6 1994-02-22
PCT/GB1995/000352 WO1995022348A1 (en) 1994-02-22 1995-02-21 Medical application of bromelain

Publications (2)

Publication Number Publication Date
MXPA96003556A MXPA96003556A (en) 1998-01-01
MX9603556A true MX9603556A (en) 1998-01-31

Family

ID=39164894

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9603556A MX9603556A (en) 1995-02-21 1995-02-21 Medical application of bromelain.

Country Status (1)

Country Link
MX (1) MX9603556A (en)

Similar Documents

Publication Publication Date Title
GB0009056D0 (en) Composition comprising free amino acids
AU6969194A (en) Compositions for use in the regulation of subnormal ph values in the intestinal tract and for treatment of bowel diseases
CA2289717A1 (en) Novel therapy for constipation
AU6649996A (en) Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
AU6915396A (en) Multiple sclerosis treatment
CA2264750A1 (en) Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
AU697311B2 (en) Combined preparation for the therapy of immunological diseases
AU9159098A (en) Use of erythropoietin and iron preparations for the production of pharmaceutical combination preparations for the treatment of rheumatic diseases
MY164077A (en) Compositions and uses of et743 for treating cancer
IL117882A0 (en) Dermatological preparation and method of treating actinic keratoses
HUP0202776A2 (en) Use of (+)-tramadol, o-demethyltramadol or(+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol or (+)-o-desmethyl-n-mono-desmethyl-tramadol for preparation pharmaceutical composition available for treating urinary incontinence
AU2304097A (en) Compositions and methods relating to drug discovery and detection and treatment of gastrointestinal diseases
AU6335496A (en) Benzothiophene compounds
CA2231176A1 (en) Long active composition for rectal administration
BG102556A (en) Orally applied pharmaceutical composition with modified release containing 5-asa, and a method for the treatment of intestinal diseases
HK1034194A1 (en) Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases.
HK1048308A1 (en) Novel compounds.
MX9603556A (en) Medical application of bromelain.
NO963482L (en) Medical application of bromelain
WO1996030016A3 (en) Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases
AU7439996A (en) Novel uses of mammalian ctla-8 and related reagents
AU7316196A (en) Diagnosis of susceptibility to cancer and treatment thereof
AU5322096A (en) Composition and process for prevention and treatment of cutaneous immediate hypersensitivity reactions
WO1997026880A3 (en) Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
UA28928A (en) Method of purulent-inflammatory desease of soft tissues